Back
Alnylam Pharmaceuticals Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
27
ALNY
Alnylam Pharmaceuticals
Last Price:
$243.38
Seasonality Move:
2.78%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
Alnylam Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 242.98 | Buy |
| 20-day SMA: | 249.04 | Sell |
| 50-day SMA: | 262.53 | Sell |
| 200-day SMA: | 221.39 | Buy |
| 8-day EMA: | 243.99 | Sell |
| 20-day EMA: | 248.09 | Sell |
| 50-day EMA: | 255.51 | Sell |
| 200-day EMA: | 234.41 | Buy |
Alnylam Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.79 | Sell |
| Relative Strength Index (14 RSI): | 42.07 | Sell |
| Chaikin Money Flow: | 207696 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (242.34 - 254.18) | Sell |
| Bollinger Bands (100): | (250.72 - 281.06) | Sell |
Alnylam Pharmaceuticals Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Alnylam Pharmaceuticals Stock
Is Alnylam Pharmaceuticals Stock a Buy?
-
Alnylam Pharmaceuticals share price is 243.25 while ALNY 8-day simple moving average is 242.98, which is a Buy signal.
-
The stock price of ALNY is 243.25 while Alnylam Pharmaceuticals 20-day SMA is 249.04, which makes it a Sell.
-
Alnylam Pharmaceuticals 50-day simple moving average is 262.53 while ALNY share price is 243.25, making it a Sell technically.
-
ALNY stock price is 243.25 and Alnylam Pharmaceuticals 200-day simple moving average is 221.39, creating a Buy signal.
ALNY Technical Analysis vs Fundamental Analysis
Sell
27
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy or a Sell?
-
Alnylam Pharmaceuticals stock is rated a SellThe current Alnylam Pharmaceuticals [ALNY] share price is $243.25. The Score for ALNY is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Alnylam Pharmaceuticals Stock Info
Market Cap:
31.4B
Price in USD:
243.25
Share Volume:
253.1K
Alnylam Pharmaceuticals 52-Week Range
52-Week High:
304.39
52-Week Low:
141.98
Sell
27
Alnylam Pharmaceuticals (ALNY)
is a Sell
Alnylam Pharmaceuticals Share Price Forecast
-
What is the Alnylam Pharmaceuticals stock price today?The Alnylam Pharmaceuticals stock price is 243.25 USD today.
-
Will ALNY stock go up or go down?Alnylam Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Alnylam Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Alnylam Pharmaceuticals is overvalued.
Is Alnylam Pharmaceuticals Stock a Buy?
-
Alnylam Pharmaceuticals share price is 243.25 while ALNY 8-day exponential moving average is 243.99, which is a Sell signal.
-
The stock price of ALNY is 243.25 while Alnylam Pharmaceuticals 20-day EMA is 248.09, which makes it a Sell.
-
Alnylam Pharmaceuticals 50-day exponential moving average is 255.51 while ALNY share price is 243.25, making it a Sell technically.
-
ALNY stock price is 243.25 and Alnylam Pharmaceuticals 200-day simple moving average is 234.41, creating a Buy signal.
Fundamental Analysis of Alnylam Pharmaceuticals
Is Alnylam Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.45 per share, and an increase next year of $0.71 per share.
Technical Analysis of Alnylam Pharmaceuticals
Should I short Alnylam Pharmaceuticals stock?
-
ALNY Moving Average Covergence Divergence (MACD) indicator is -4.79, suggesting Alnylam Pharmaceuticals is a Sell
-
Alnylam Pharmaceuticals Relative Strength Index (RSI) is 42.07, which suggest Alnylam Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Alnylam Pharmaceuticals is (242.34 - 254.18), which suggest Alnylam Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Alnylam Pharmaceuticals is (250.72 - 281.06), which suggest Alnylam Pharmaceuticals is a Sell
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.